NEWSROOM | Galderma

Galderma Launches EMERVEL® Range of Hyaluronic Acid Dermal Fillers

Galderma announces Results of largest-ever Rosacea Trial

Cetaphil® Brand Launches Cetaphil® Restoraderm® -- a new Line of Products to Help

Galderma Received FDA Approval of Differin® (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation

Azzalure ® approved in Spain for aesthetic use in the treatment of glabellar lines

Azzalure ® approved in Germany for aesthetic use in the treatment of glabellar lines

Azzalure ® is approved in France for aesthetic use in the treatment of frown lines

Azzalure ® approved in the UK for aesthetic use in the treatment of glabellar lines

Galderma wins FDA Approval for Vectical ™ Ointment

The Health Authorities of 15 European countries give a collective green light to Azzalure ®

Galderma announces availability of Epiduo ™ Gel in the USA

Galderma announces Approval for Differin ® Gel 0.1% in Japan